These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6974869)

  • 21. Potentiated 5-hydroxytryptophan induced response suppression in rats following chronic reserpine.
    Brugge KL; Hingtgen JN; Aprison MH
    Pharmacol Biochem Behav; 1987 Feb; 26(2):287-91. PubMed ID: 3495008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facilitated shock-induced aggression after chronic treatment with antidepressant drugs in the rat.
    Mogilnicka E; Przewłocka B
    Pharmacol Biochem Behav; 1981 Feb; 14(2):129-32. PubMed ID: 7193878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat.
    Chaput Y; de Montigny C; Blier P
    Neuropsychopharmacology; 1991 Dec; 5(4):219-29. PubMed ID: 1839498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additional evidence that L-5-hydroxytryptophan discrimination models a unique serotonin receptor.
    Friedman R; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 1983; 80(3):209-13. PubMed ID: 6137018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of serotonin in the regulation of beta-adrenoceptors by antidepressants.
    Asakura M; Tsukamoto T; Kubota H; Imafuku J; Ino M; Nishizaki J; Sato A; Shinbo K; Hasegawa K
    Eur J Pharmacol; 1987 Sep; 141(1):95-100. PubMed ID: 2822448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
    Arnt J; Hyttel J; Overø KF
    Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pretreatment with clonidine, lithium and quinine on the activities of antidepressant drugs in the mouse tail suspension test.
    Redrobe JP; Bourin M
    Fundam Clin Pharmacol; 1997; 11(5):381-6. PubMed ID: 9342590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of repeated administration of imipramine, citalopram and mianserin on responsiveness of central serotonergic, alpha 2-adrenergic and cholinergic system in mice.
    Maj J; Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1989; 41(4):313-9. PubMed ID: 2561380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
    Jørgensen H; Knigge U; Warberg J
    Neuroendocrinology; 1992 Mar; 55(3):336-43. PubMed ID: 1386914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of trazodone, mianserin, iprindole and zimelidine on wet dog shakes produced by carbachol in rats.
    Turski L; Czuczwar SJ; Turski W; Kleinrok Z
    J Pharm Pharmacol; 1981 Oct; 33(10):670-1. PubMed ID: 6117624
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of antidepressants on behavioral despair in rats.
    Górka Z; Wojtasik E
    Pol J Pharmacol Pharm; 1980; 32(4):463-8. PubMed ID: 7196038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phencyclidine-induced wet-dog shakes observed in rats after withdrawal from reserpine treatment.
    Nabeshima T; Yamaguchi K; Yoshida S; Furukawa H; Kameyama T
    Pharmacol Biochem Behav; 1986 May; 24(5):1275-9. PubMed ID: 3725829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine.
    Maj J; Rogóz Z; Skuza G; Sowińska H
    J Neural Transm; 1984; 60(3-4):273-82. PubMed ID: 6241227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical antidepressant drugs - psychopharmacological profile and mechanism of action.
    Maj J
    Pharmacopsychiatria; 1982 Jan; 15(1):26-30. PubMed ID: 7199735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mianserin, danitracen and amitriptyline withdrawal increases the behavioural responses of rats to L-5-HTP.
    Mogilnicka E; Klimek V
    J Pharm Pharmacol; 1979 Oct; 31(10):704-5. PubMed ID: 41046
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhancement of 5-hydroxytryptamine-induced behavioral effects following chronic administration of antidepressant drugs.
    Jones RS
    Psychopharmacology (Berl); 1980; 69(3):307-11. PubMed ID: 6774372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of angiotensin II on some behavioral and neurochemical measures of the central serotonine system.
    Braszko JJ; Majewski K; Maciejewski A; Wisniewski K
    Biomed Biochim Acta; 1985; 44(9):1359-68. PubMed ID: 3878708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chronic antidepressant treatment on serotonin receptor activity in mice.
    Friedman E; Cooper TB; Dallob A
    Eur J Pharmacol; 1983 Apr; 89(1-2):69-76. PubMed ID: 6861891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-dependent down-regulation of beta-adrenergic receptors after chronic intravenous infusion of antidepressants.
    Sethy VH; Day JS; Cooper MM
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):673-82. PubMed ID: 2851860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.